Home » Topics » BioWorld Science

BioWorld Science
RSS

Duke University presents new pro-N-cadherin-targeting humanized antibodies

Dec. 16, 2020

SMAD3 as new therapeutic target for NSCLC

Dec. 16, 2020

Merck & Co. discovers new compounds for HIV infection

Dec. 16, 2020

Medshine Discovery identifies new RIP-1 inhibitors

Dec. 16, 2020

Merck & Co. patents NPR1 agonists

Dec. 16, 2020

First patients enrolled in phase IIb study of rNAPc2 for COVID-19

Dec. 16, 2020

Voronoi discloses new RET inhibitors

Dec. 16, 2020

Phase I results show safety and activity with rintodestrant in ER+/HER2- breast cancer

Dec. 16, 2020

Initiation of first-in-human study of CVB vaccine candidate, PRV-101

Dec. 16, 2020

Positive phase II data for PL-9643 in patients with moderate to severe dry eye disease

Dec. 16, 2020

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...